Medicare Enrolled

Dr. Lisa Neuenfeldt, APRN

Oncology Clinical Nurse Specialist · Panama City, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2100 STATE AVE, Panama City, FL 32405
8507630036
In practice since 2010 (16 years)
NPI: 1619290673 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Neuenfeldt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neuenfeldt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Neuenfeldt

Dr. Lisa Neuenfeldt is an oncology clinical nurse specialist in Panama City, FL, with 16 years in practice. Based on federal Medicare data, Dr. Neuenfeldt performed 263 Medicare services across 208 unique beneficiaries.

Between the years covered by Open Payments, Dr. Neuenfeldt received a total of $7,985 from 63 pharmaceutical and/or device companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in oncology clinical nurse specialist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Neuenfeldt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 14% volume in FL$ $7,985 industry payments

Medicare Practice Summary

Medicare Utilization ↗
263
Medicare services
Top 14% in FL for oncology clinical nurse specialist
208
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)153$83$224
Office visit, established patient (20-29 min)110$60$148
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,985
Total received (2021-2024)
Avg $1,996/year across 4 years
Top 14% in FL for oncology clinical nurse specialist
63
Companies
397
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,578 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$407 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,919
2023
$1,159
2022
$2,464
2021
$2,443

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,062
Celgene Corporation
$610
Amgen Inc.
$504
Janssen Biotech, Inc.
$411
Regeneron Healthcare Solutions, Inc.
$341
Daiichi Sankyo Inc.
$332
E.R. Squibb & Sons, L.L.C.
$290
BeiGene USA, Inc.
$285
AstraZeneca Pharmaceuticals LP
$283
Incyte Corporation
$267
Merck Sharp & Dohme LLC
$249
Ipsen Biopharmaceuticals, Inc
$219
GENZYME CORPORATION
$212
Eisai Inc.
$197
Pharmacyclics LLC, An AbbVie Company
$154
Seagen Inc.
$154
G1 Therapeutics, Inc.
$150
ARRAY BIOPHARMA INC
$145
JAZZ PHARMACEUTICALS INC.
$137
Pharmacyclics LLC, an AbbVie Company
$130
ABBVIE INC.
$118
PFIZER INC.
$117
Merck Sharp & Dohme Corporation
$102
Octapharma USA, Inc.
$101
Blueprint Medicines Corporation
$98
Coherus Biosciences Inc.
$98
Astellas Pharma US Inc
$82
Takeda Pharmaceuticals U.S.A., Inc.
$79
Deciphera Pharmaceuticals Inc.
$65
Taiho Oncology, Inc.
$64
GlaxoSmithKline, LLC.
$53
Myriad Genetic Laboratories, Inc.
$49
Karyopharm Therapeutics Inc.
$48
AVEO Pharmaceuticals, Inc.
$46
Gilead Sciences, Inc.
$45
TerSera Therapeutics LLC
$42
Lilly USA, LLC
$41
CSL Behring
$41
Progenics Pharmaceuticals, Inc.
$37
Aveo Pharmaceuticals, Inc.
$36
ADC Therapeutics America, Inc.
$33
Genentech USA, Inc.
$31
Mirati Therapeutics, Inc.
$30
EUSA Pharma (US) LLC
$29
PharmaEssentia USA Corporation
$27
EISAI INC.
$26
Global Blood Therapeutics, Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
Epizyme, Inc.,
$24
Rigel Pharmaceuticals, Inc.
$22
Acceleron Pharma, Inc.
$20
SOBI, INC
$19
Dova Pharmaceuticals
$18
PROGENICS PHARMACEUTICALS, INC.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
ImmunoGen, Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Agios Pharmaceuticals, Inc.
$16
Boston Scientific Corporation
$16
Apellis Pharmaceuticals, Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
Alnylam Pharmaceuticals Inc.
$15
MorphoSys, US Inc.
$13
Top 3 companies account for 27.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · BESREMI · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · CALQUENCE · CARVYKTI · COSELA · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · FOTIVDA · Fabhalta · GAVRETO · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · Idelvion · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PLUVICTO · PROMACTA · PYLARIFY · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Reblozyl · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIVDAK · Tavalisse · Tecentriq · Trodelvy · Udenyca · VALCHLOR · VENCLEXTA · VERZENIO · WATCHMAN Access System · XALKORI · XPOVIO · XTANDI · Xofigo · Xospata · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,036 per 100 Medicare services performed
Looking for a oncology clinical nurse specialist in Panama City?
Compare oncology clinical nurse specialists in the Panama City area by procedure volume, costs, and industry payment transparency.
Browse oncology clinical nurse specialists nearby

Geographic Context

Oncology Clinical Nurse Specialists within 10 mi
1
Per 100K population
0.6
County median income
$70,188
Nearest hospital
HCA FLORIDA GULF COAST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Neuenfeldt is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and high industry engagement (low-engagement, top 14%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Neuenfeldt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Neuenfeldt performed 153 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Neuenfeldt receive payments from pharmaceutical companies?
Yes. Dr. Neuenfeldt received a total of $7,985 from 63 companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neuenfeldt's costs compare to other oncology clinical nurse specialists in Panama City?
Dr. Neuenfeldt's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neuenfeldt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →